Home  »  Stock   »  The countdown is on: AstraZeneca PLC (AZN)...

The countdown is on: AstraZeneca PLC (AZN)

AstraZeneca PLC (AZN) is priced at $68.18 after the most recent trading session. At the very opening of the session, the stock price was $69.51 and reached a high price of $69.63, prior to closing the session it reached the value of $69.15. The stock touched a low price of $68.585.Recently in News on January 23, 2023, AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.. AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor), for $26 per share in cash at closing, plus a non-tradable contingent value right of $10 per share in cash payable upon a specified regulatory submission for a baxdrostat product. On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender offer, CinCor will become a subsidiary of AstraZeneca. You can read further details here

AstraZeneca PLC had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $72.12 on 01/10/23, with the lowest value was $68.32 for the same time period, recorded on 01/23/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


AstraZeneca PLC (AZN) full year performance was 16.26%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AstraZeneca PLC shares are logging -5.47% during the 52-week period from high price, and 29.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $52.65 and $72.12.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2937549 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the AstraZeneca PLC (AZN) recorded performance in the market was 1.99%, having the revenues showcasing 26.86% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 219.23B, as it employees total of 83100 workers.

The Analysts eye on AstraZeneca PLC (AZN)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 62.72, with a change in the price was noted +2.51. In a similar fashion, AstraZeneca PLC posted a movement of +3.81% for the period of last 100 days, recording 5,869,303 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AZN is recording 0.83 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.67.

Technical rundown of AstraZeneca PLC (AZN)

Raw Stochastic average of AstraZeneca PLC in the period of last 50 days is set at 66.13%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 24.32%. In the last 20 days, the company’s Stochastic %K was 44.08% and its Stochastic %D was recorded 58.96%.

Considering, the past performance of AstraZeneca PLC, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 1.99%. Additionally, trading for the stock in the period of the last six months notably improved by 5.80%, alongside a boost of 16.26% for the period of the last 12 months. The shares increased approximately by -1.33% in the 7-day charts and went down by 2.49% in the period of the last 30 days. Common stock shares were driven by 26.86% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts